Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026

Core Viewpoint - Orion Corporation has transferred 172,778 of its own B shares as part of a share reward for the earning period 2023–2025, in accordance with the Share-based Incentive Plan [1][2] Group 1: Share Transfer Details - The transfer of shares was authorized by the Annual General Meeting held on 23 March 2022 [2] - After the transfer, Orion Corporation holds a total of 268,166 own B shares [2] Group 2: Company Overview - Orion Pharma is a Nordic pharmaceutical company with over a hundred years of experience, focusing on developing, manufacturing, and marketing human and veterinary pharmaceuticals [2] - The company reported net sales of EUR 1,890 million in 2025 and employs approximately 4,000 professionals globally [2] - Core therapy areas for Orion's pharmaceutical R&D include oncology and pain management, with proprietary products aimed at treating cancer, respiratory diseases, and neurological diseases [2]